Establishment Labs Holdings Inc. $ESTA Stake Lessened by Voya Investment Management LLC

Voya Investment Management LLC cut its holdings in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 48.9% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 208,723 shares of the company’s stock after selling 199,539 shares during the quarter. Voya Investment Management LLC owned 0.72% of Establishment Labs worth $8,517,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. ANTIPODES PARTNERS Ltd acquired a new position in Establishment Labs in the first quarter worth approximately $81,000. Elevation Point Wealth Partners LLC acquired a new stake in shares of Establishment Labs in the 1st quarter valued at $207,000. Patriot Financial Group Insurance Agency LLC bought a new stake in Establishment Labs in the first quarter worth $234,000. ADAR1 Capital Management LLC acquired a new position in Establishment Labs during the first quarter worth $326,000. Finally, New York State Common Retirement Fund bought a new position in Establishment Labs during the first quarter valued at about $894,000. 72.91% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

ESTA has been the subject of a number of analyst reports. Wall Street Zen cut Establishment Labs from a “hold” rating to a “sell” rating in a research report on Saturday, August 16th. Canaccord Genuity Group initiated coverage on Establishment Labs in a report on Wednesday, August 20th. They issued a “buy” rating and a $60.00 target price for the company. Needham & Company LLC reiterated a “buy” rating and set a $48.00 price target on shares of Establishment Labs in a report on Friday, June 13th. Citigroup lifted their price target on shares of Establishment Labs from $38.00 to $47.00 and gave the company a “neutral” rating in a research report on Wednesday, July 9th. Finally, Mizuho boosted their price objective on shares of Establishment Labs from $58.00 to $70.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 16th. Five equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $56.50.

Establishment Labs Trading Down 0.1%

Shares of ESTA stock opened at $39.10 on Thursday. The firm has a market capitalization of $1.13 billion, a P/E ratio of -12.82 and a beta of 0.85. Establishment Labs Holdings Inc. has a 1 year low of $26.56 and a 1 year high of $50.85. The firm’s fifty day simple moving average is $40.45 and its 200 day simple moving average is $37.96. The company has a current ratio of 2.84, a quick ratio of 1.67 and a debt-to-equity ratio of 9.71.

Establishment Labs (NASDAQ:ESTA) last issued its quarterly earnings results on Thursday, August 7th. The company reported ($0.57) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.54) by ($0.03). Establishment Labs had a negative net margin of 49.89% and a negative return on equity of 224.34%. The company had revenue of $51.30 million during the quarter, compared to the consensus estimate of $50.80 million. During the same period last year, the company earned ($0.62) earnings per share. Establishment Labs’s revenue for the quarter was up 16.1% on a year-over-year basis. Establishment Labs has set its FY 2025 guidance at EPS. As a group, sell-side analysts predict that Establishment Labs Holdings Inc. will post -2.41 EPS for the current year.

Establishment Labs Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.